Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Specialized housing and transportation needs of adults with multiple sclerosis.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
[Pathogenesis of neuromyelitis optica].
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Neurologic Complications Caused by Epstein-Barr Virus in Pediatric Patients.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Voice-related quality of life in patients with multiple sclerosis.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »